Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction

NCT: NCT07820410 · RECRUITING

NCT IDNCT07820410
StatusRECRUITING
Start Date2024-11-25
Completion2027-12-31
SponsorBeijing Anzhen Hospital (OTHER)
First posted
Last updated

Brief Summary

To evaluate the safety and effectiveness of the Atrial Shunt for the treatment of heart failure with reduced ejection fraction (HFrEF)

Frequently Asked Questions

What is Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction?

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction is a clinical trial registered under NCT07820410. Current status: RECRUITING.

What is the status of NCT07820410?

The current status of NCT07820410 (Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction) is: RECRUITING.

When did Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction start?

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction started on 2024-11-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑